Baxdela Delafloxacin Moxeparvovec-Roki 300 mg Injection Powder Vial 10 Pack (RX)

Baxdela Delafloxacin 300 mg Injection Powder Vial is an antibiotic used to treat acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible bacteria. It's particularly effective against resistant strains like MRSA (Methicillin-resistant Staphylococcus aureus). As a fluoroquinolone antibiotic, Baxdela works by inhibiting bacterial DNA gyrase and topoisomerase IV, essential for DNA replication and repair. This broad-spectrum antibiotic is administered intravenously and helps reduce infection duration, alleviate symptoms, and prevent complications in serious bacterial infections.

Baxdela (Delafloxacin) 300 mg Injection Powder Vial by Melinta Therapeutics is an advanced fluoroquinolone antibiotic designed for the treatment of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP) in adults. This injectable formulation is particularly useful in hospital settings, allowing for effective management of severe infections where intravenous administration is required. Each box contains 10 vials, providing a suitable quantity for multiple dosing and patient management as determined by a healthcare provider.

Professional-Grade Sclerotherapy: Asclera® Polidocanol Injection 0.5% by Methapharm

Restore confidence in your legs with safe, effective, and clinically-proven spider vein treatment using Asclera® (Polidocanol Injection) 0.5% (NDC: 67850-0140-05) by Methapharm. Trusted by vein specialists and dermatologists worldwide, Asclera® provides fast, targeted relief for unsightly spider veins and uncomplicated reticular veins with minimal discomfort and downtime—delivered in convenient 2 mL ampules (5 per package) for professional use.

Uses

• Sclerotherapy for Spider Veins (Telangiectasias): Asclera® is FDA-approved for treating uncomplicated spider veins (≤1 mm in diameter).
• Treatment of Reticular Veins: Effective on uncomplicated reticular veins (1–3 mm in diameter) on the legs.
• Non-Surgical Vein Therapy: A minimally invasive option for vein removal without surgery or significant recovery.

Benefits

• Fast, Visible Results: Noticeably reduces the appearance of spider and reticular veins after a single in-office session.
• Minimally Invasive: No need for anesthesia, incisions, or long downtime—walk-in, walk-out treatment.
• Advanced Safety Profile: FDA-approved polidocanol is well-tolerated with a low risk of hyperpigmentation and necrosis when administered professionally.
• Precision Packaging: Each box includes 5 sterile ampules, each containing 10 mg (2 mL of 0.5% solution), ensuring consistent, accurate dosing.
• Patient-Preferred: Minimal pain or burning compared to older sclerosing agents; ideal for sensitive patients.

Details and Features:

• Active Ingredient: Each vial contains delafloxacin 300 mg in powder form, which must be reconstituted for intravenous infusion.
  
• Packaging: Supplied in a pack of 10 vials, catering to needs in clinical and hospital environments.
  
• Spectrum of Activity: Effective against a broad range of gram-positive and gram-negative pathogens, including MRSA, providing comprehensive infection management.
  
• Administration: Intended for intravenous administration, suitable for patients who are unable to take oral medications or require immediate therapeutic intervention.
  
• Usage Indication: Approved for the treatment of ABSSSI and CABP caused by susceptible strains of bacteria.

Mechanism of Action:

Delafloxacin targets bacterial DNA replication enzymes, namely DNA gyrase and topoisomerase IV. By inhibiting these critical enzymes, it prevents DNA replication and transcription within the bacteria, leading to cell death. This dual mechanism of action contributes to its efficacy across a diverse range of bacterial pathogens.

Specifications

Directions

For administration by trained healthcare professionals only.

1. Patient Evaluation: Confirm indication (spider or reticular veins) and rule out contraindications.
2. Injection Procedure:
   • Use aseptic technique.
   • Inject solution directly into the targeted vein using a fine needle (sclerotherapy protocol).
   • Maximum dose and number of veins per session determined by patient tolerance and physician discretion.
3. Post-Procedure Care:
   • Apply mild compression and encourage ambulation.
   • Advise patients to wear compression stockings as directed and avoid heavy exercise for several days.
   • Schedule follow-up as needed.

Refer to the full prescribing information for detailed procedural instructions and dosing guidelines.

Side Effects

Common Side Effects:

• Mild injection site pain, irritation, redness, or swelling
• Temporary bruising or discoloration
• Local itching or mild burning

Less Common/Rare Side Effects:

• Allergic reactions
• Skin ulceration or hyperpigmentation
• Blood clots in treated vein (thrombophlebitis)
• Headache, dizziness, or fainting

Contact your healthcare provider if severe or persistent reactions occur.

Warnings

• For Professional Use Only: Not for self-injection or use by untrained personnel.
• Contraindications:
  • Patients with acute vein or blood clotting disorders
  • Known allergy to polidocanol or formulation components
  • Pregnant or breastfeeding women (unless directed by a physician)
• Avoid Arterial Injection: Strictly for intravenous use; inadvertent arterial administration can cause severe complications.
• Monitor for Allergic Reactions: Immediate treatment may be necessary if anaphylactic reaction occurs.
• Post-Treatment Monitoring: Advise patients of possible delayed reactions and when to call their provider.

Why Choose Asclera® (Polidocanol Injection) 0.5% by Methapharm?

Asclera® is the leading, physician-trusted injectable for cosmetic spider vein treatment, offering reliable efficacy, a gentle experience, and precision dosing in every ampule. Its well-studied safety and fast results make it a top choice for vein clinics and dermatology practices seeking the best for their patients.

Baxdela 300 mg Injection Powder Vial offers a powerful solution for managing serious bacterial infections in adult patients. Healthcare providers should ensure appropriate use by considering the risks, monitoring patients for adverse effects, and facilitating safe administration.

Order Asclera® (Polidocanol Injection) 0.5% (5 Ampules x 2 mL) by Methapharm (NDC: 67850-0140-05) today and partner with the gold standard in sclerotherapy.